Stop advertising

Overview of attention for article published in Drug & Therapeutics Bulletin, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 794)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 15 tweets from 9 users, with an upper bound of 106,940 followers.

@pash22 @US_FDA @EMA_News @MHRAgovuk @dariustahir @hnorms @JAHCave @DTB_BMJ that talk about "blockbuster new drug [interest drug of choice] approved for use!" https://t.co/ybIGBASPF2 The cat is way way out of the bag with these ones

A review of 2022 In October, we took NHS England, NICE and the MHRA to task for 'advertising' medicines through their press releases. https://t.co/9QTF313jSd https://t.co/oHj0V6HLNf

RT @DTB_BMJ: Why we think that phrases such as “cutting edge,” “game changing,” and “ground breaking” have no place in press releases about…

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 11 additional tweets.